| J9271 | Injection, pembrolizumab, 1 mg | 36,800 | $40 | $1.6M |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 32,220 | $40 | $1.2M |
| J0897 | Injection, denosumab, 1 mg | 10,380 | $20 | $197.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,430 | $100 | $145.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 520 | $150 | $77K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 480 | $120 | $57.7K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 18,700 | $1 | $37.4K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 210 | $100 | $21.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 280 | $70 | $18.6K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 100 | $180 | $18K |